ZA200200800B - Pharmaceutically stable oxaliplatinum preparation for parenteral administration. - Google Patents

Pharmaceutically stable oxaliplatinum preparation for parenteral administration. Download PDF

Info

Publication number
ZA200200800B
ZA200200800B ZA200200800A ZA200200800A ZA200200800B ZA 200200800 B ZA200200800 B ZA 200200800B ZA 200200800 A ZA200200800 A ZA 200200800A ZA 200200800 A ZA200200800 A ZA 200200800A ZA 200200800 B ZA200200800 B ZA 200200800B
Authority
ZA
South Africa
Prior art keywords
oxaliplatinum
pharmaceutical preparation
solvent
preparation according
preparation
Prior art date
Application number
ZA200200800A
Other languages
English (en)
Inventor
Houssam Ibrahim
Henri Pourrat
Martine Bayssas
Christine Deuschel
Original Assignee
Debiopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm Sa filed Critical Debiopharm Sa
Publication of ZA200200800B publication Critical patent/ZA200200800B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
ZA200200800A 1999-08-30 2002-01-29 Pharmaceutically stable oxaliplatinum preparation for parenteral administration. ZA200200800B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15135799P 1999-08-30 1999-08-30

Publications (1)

Publication Number Publication Date
ZA200200800B true ZA200200800B (en) 2003-06-25

Family

ID=22538394

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200200800A ZA200200800B (en) 1999-08-30 2002-01-29 Pharmaceutically stable oxaliplatinum preparation for parenteral administration.

Country Status (19)

Country Link
EP (1) EP1207875B1 (cs)
JP (1) JP4890711B2 (cs)
KR (1) KR100688217B1 (cs)
CN (1) CN1170533C (cs)
AT (1) ATE249825T1 (cs)
AU (1) AU768169B2 (cs)
BR (1) BRPI0013613B8 (cs)
CA (1) CA2382389C (cs)
CZ (1) CZ298581B6 (cs)
DE (1) DE60005376T2 (cs)
DK (1) DK1207875T3 (cs)
ES (1) ES2206288T3 (cs)
HK (1) HK1048266B (cs)
MX (1) MXPA02002266A (cs)
PT (1) PT1207875E (cs)
RU (1) RU2252022C2 (cs)
UA (1) UA71985C2 (cs)
WO (1) WO2001015691A1 (cs)
ZA (1) ZA200200800B (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7012072B2 (en) 2000-12-12 2006-03-14 Debiopharm S.A. Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
TWI236486B (en) * 2001-10-10 2005-07-21 Mitsui Chemicals Inc Crosslinkable aromatic resin having protonic acid group, and ion conductive polymer membrane, binder and fuel cell using the resin
US6476068B1 (en) * 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
DE10314377A1 (de) * 2003-03-28 2004-10-07 Stada Arzneimittel Ag Gebrauchsfertige Oxaliplatin-Lösungen
GB2421911A (en) 2003-08-28 2006-07-12 Mayne Pharma Pty Ltd Acid containing oxaliplatin formulations
CZ300795B6 (cs) * 2003-09-02 2009-08-12 Pliva-Lachema A. S. Farmaceutická kompozice a zpusob její výroby
EP2330110A1 (en) 2003-11-25 2011-06-08 Platco Technologies (Proprietary) Limited Platinum(II) complexes, preparation and use
SI1789427T1 (sl) 2004-09-01 2009-10-31 Platco Technologies Proprietar Priprava kompleksov platine(II)
DE102004052877B4 (de) 2004-11-02 2008-06-19 Ebewe Pharma Ges.M.B.H. Nfg.Kg Stabile wässrige Formulierungen eines Platin-Derivats
CN1311818C (zh) * 2004-11-22 2007-04-25 山东蓝金生物工程有限公司 一种抗实体肿瘤的药物组合物
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
WO2007029268A2 (en) * 2005-09-05 2007-03-15 Dabur Pharma Limited Stable oxaliplatin formulation
US7956208B2 (en) 2006-01-30 2011-06-07 Platco Technologies (Proprietary) Limited Preparation of platinum (II) complexes
CZ300665B6 (cs) * 2007-01-22 2009-07-15 Pliva-Lachema A. S. Sterilní kapalná farmaceutická kompozice a zpusob její výroby
CZ300664B6 (cs) * 2007-01-22 2009-07-15 Pliva-Lachema A. S. Sterilní kapalná farmaceutická kompozice a zpusob její výroby
KR200449655Y1 (ko) * 2009-11-20 2010-07-28 김명환 보조손잡이캡이 부설된 밀폐형 접이식 우산
JP5661912B2 (ja) * 2010-03-18 2015-01-28 イノファーマ，インコーポレイテッド 安定なボルテゾミブ製剤
US8263578B2 (en) 2010-03-18 2012-09-11 Innopharma, Inc. Stable bortezomib formulations
CN102670526B (zh) * 2012-05-10 2013-12-04 南京臣功制药股份有限公司 奥沙利铂冻干粉针剂及其制备方法
JP5314790B1 (ja) * 2012-07-09 2013-10-16 東和薬品株式会社 オキサリプラチン含有医薬組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994012193A1 (fr) * 1992-11-24 1994-06-09 Debiopharm S.A. Combinaison de cisplatine avec l'oxaliplatine
US5455270A (en) * 1993-08-11 1995-10-03 Bristol-Myers Squibb Co. Stabilized solutions of platinum(II) antitumor agents
US5716988A (en) * 1994-08-08 1998-02-10 Debiopharm S.A. Pharmaceutically stable preparation of oxaliplatinum
CA2281807C (en) * 1997-03-07 2007-10-16 Sanofi Pharmaceuticals, Inc. Method of treating a tumor
JP3774043B2 (ja) * 1997-09-12 2006-05-10 彰 辻 悪性腫瘍診断剤
GB9804013D0 (en) * 1998-02-25 1998-04-22 Sanofi Sa Formulations

Also Published As

Publication number Publication date
EP1207875B1 (fr) 2003-09-17
CN1170533C (zh) 2004-10-13
UA71985C2 (uk) 2005-01-17
BR0013613B1 (pt) 2013-05-28
KR100688217B1 (ko) 2007-02-28
DE60005376T2 (de) 2004-07-01
EP1207875A1 (fr) 2002-05-29
CZ298581B6 (cs) 2007-11-14
JP2003508436A (ja) 2003-03-04
CA2382389C (fr) 2010-06-29
WO2001015691A1 (fr) 2001-03-08
AU768169B2 (en) 2003-12-04
HK1048266A1 (en) 2003-03-28
PT1207875E (pt) 2004-02-27
HK1048266B (zh) 2005-04-01
AU6553000A (en) 2001-03-26
RU2252022C2 (ru) 2005-05-20
ATE249825T1 (de) 2003-10-15
CZ2002291A3 (cs) 2002-10-16
DK1207875T3 (da) 2004-01-19
DE60005376D1 (de) 2003-10-23
KR20020033782A (ko) 2002-05-07
BRPI0013613B8 (pt) 2021-05-25
CA2382389A1 (fr) 2001-03-08
JP4890711B2 (ja) 2012-03-07
CN1371278A (zh) 2002-09-25
MXPA02002266A (es) 2003-08-20
ES2206288T3 (es) 2004-05-16
BR0013613A (pt) 2002-05-14

Similar Documents

Publication Publication Date Title
AU768169B2 (en) Pharmaceutically stable oxaliplatinum preparation for parenteral administration
KR100258423B1 (ko) 오메프라졸 및 그의 동족체를 함유하는 주사제 및 주사제 키트
US9095514B2 (en) Pharmaceutical composition
HU202761B (en) Process for producing stabilized erythropoietin compositions
EP0650729B1 (en) Rapamycin formulations for IV injection
JPH07149624A (ja) 静脈注射用のラパマイシン製剤
SK285650B6 (sk) Vodné prípravky moxifloxacínu a chloridu sodného,spôsob ich výroby a kombinovaný preparát
JP2012102120A (ja) 非経口投与を目的とするビンフルニンの医薬組成物、その調製方法およびその使用
EP0336200A1 (en) Pharmaceutical compositions of piroxicam in aqueous solutions and process for their preparation
RO113303B1 (ro) Solutie de piroxicam, cu stabilitate marita
KR101807462B1 (ko) 보르테조밉을 포함하는 안정한 제제 및 이의 제조방법
JPH0525857B2 (cs)
US7070796B1 (en) Pharmaceutically stable oxaliplatinum preparation for parenteral administration
HU191538B (en) Process for producing pharmaceutical compositions containing acid additional salts of vinca-dimeres
CN101716138B (zh) 一种含有盐酸替罗非班的注射液
HU186489B (en) Process for producing pharmaceutical composition containing liophylized penicillin derivatives
EP3632411B1 (en) Improved kit for preparing injectable carmustine solutions
JP2654518B2 (ja) 肝細胞増殖促進剤
CA2001643A1 (en) Preservative-free multi-dose vincristine solution
WO2011101865A2 (en) Stable pharmaceutical compositions of clopidogrel for parenteral delivery
HK1089105B (en) Pharmaceutical composition of vinflunine for parenteral administration, preparation method thereof and use of same